David Lustig

Having Lost 1/3 of Its Value in 2 Days Teva Drags Down Tel Aviv Exchange, Layoffs to Follow

By JNi.Media

This collapse comes in the wake of the world's biggest generic drugs maker attempt to dominate its market with a $40.5 billion acquisition of Allergan's generics business last year. It was a bad call.